Intel Buys the Company That Gives Machines “The Power of Sight”
Having missed out on the mobile chip market, and lagging behind in supplying the hardware for the burgeoning field of AI, Intel wants to acquire its way to the vanguard of the next emerging trend. Its latest move: buying up Movidius, a firm that makes computer vision chips used in drones and smart devices.
The self-stated mission of Movidius, one of MIT Technology Review's 50 Smartest Companies of 2016, is to give machines “the power of sight,” a goal they primarily achieve using their “vision processing units.” The chips have already found their way into drones made by DJI, where they are used to sense and avoid obstacles, and Google’s augmented reality system Tango.

In a statement, Movidius cited Intel’s RealSense technology as a reason why the deal was a good fit—Intel was already on the path to advanced computer vision using its own 3-D cameras. Josh Walden, a senior vice president at Intel, says software as much as hardware makes Movidius useful to the company. Movidius’s deep-learning algorithms are tailor-made for computer vision, and Walden says Intel sees great promise (read: big bucks) in the realm of devices that can see and make sense of their surroundings.
Nvidia, which dominates the market for deep-learning-focused chips, is bound to give all comers a run for their money. But Intel is betting that even though the deep-learning market is still very small compared to the company’s overall revenue, purchasing Movidius gets it in on the ground floor of the next big thing.
(Read more: Recode, “50 Smartest Companies, 2016,” “The Next Must-Have Smartphone Feature,” “Intel Outside as Other Companies Prosper from AI Chips”)
Keep Reading
Most Popular

Toronto wants to kill the smart city forever
The city wants to get right what Sidewalk Labs got so wrong.

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging
The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun has a bold new vision for the future of AI
One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

The dark secret behind those cute AI-generated animal images
Google Brain has revealed its own image-making AI, called Imagen. But don't expect to see anything that isn't wholesome.
Stay connected

Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.